Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis

Springer Science and Business Media LLC - Tập 15 Số 1 - Trang 1-19 - 2023
Zhou, Futao1, Sun, Yangyan1, Xie, Xinhua2, Zhao, Yushi1
1School of Basic Medicine, Gannan Medical University, Ganzhou City, China
2Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, China

Tóm tắt

Chemokines, which are chemotactic inflammatory mediators involved in controlling the migration and residence of all immune cells, are closely associated with brain inflammation, recognized as one of the potential processes/mechanisms associated with cognitive impairment. We aim to determine the chemokines which are significantly altered in Alzheimer’s disease (AD) and mild cognitive impairment (MCI), as well as the respective effect sizes, by performing a meta-analysis of chemokines in cerebrospinal fluid (CSF) and blood (plasma or serum). We searched three databases (Pubmed, EMBASE and Cochrane library) for studies regarding chemokines. The three pairwise comparisons were as follows: AD vs HC, MCI vs healthy controls (HC), and AD vs MCI. The fold-change was calculated using the ratio of mean (RoM) chemokine concentration for every study. Subgroup analyses were performed for exploring the source of heterogeneity. Of 2338 records identified from the databases, 61 articles comprising a total of 3937 patients with AD, 1459 with MCI, and 4434 healthy controls were included. The following chemokines were strongly associated with AD compared with HC: blood CXCL10 (RoM, 1.92, p = 0.039), blood CXCL9 (RoM, 1.78, p < 0.001), blood CCL27 (RoM, 1.34, p < 0.001), blood CCL15 (RoM, 1.29, p = 0.003), as well as CSF CCL2 (RoM, 1.19, p < 0.001). In the comparison of AD with MCI, there was significance for blood CXCL9 (RoM, 2.29, p < 0.001), blood CX3CL1 (RoM, 0.77, p = 0.017), and blood CCL1 (RoM, 1.37, p < 0.001). Of the chemokines tested, blood CX3CL1 (RoM, 2.02, p < 0.001) and CSF CCL2 (RoM, 1.16, p = 0.004) were significant for the comparison of MCI with healthy controls. Chemokines CCL1, CCL2, CCL15, CCL27, CXCL9, CXCL10, and CX3CL1 might be most promising to serve as key molecular markers of cognitive impairment, although more cohort studies with larger populations are needed.

Tài liệu tham khảo

WHO. WHO's annual World Health Statistics reports: risks of health. Geneva: World Health Organization. 2021.

citation_journal_title=Alzheimers Res Ther; citation_title=Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval; citation_author=M Tolar, S Abushakra, JA Hey, A Porsteinsson; citation_volume=12; citation_publication_date=2020; citation_pages=95; citation_doi=10.1186/s13195-020-00663-w; citation_id=CR2

citation_journal_title=Nat Rev Neurol; citation_title=Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?; citation_author=F Leng, P Edison; citation_volume=17; citation_publication_date=2021; citation_pages=157-172; citation_doi=10.1038/s41582-020-00435-y; citation_id=CR3

citation_journal_title=J Neuropathol Exp Neurol; citation_title=Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature; citation_author=PT Nelson, I Alafuzoff, EH Bigio, C Bouras; citation_volume=71; citation_publication_date=2012; citation_pages=362-381; citation_doi=10.1097/NEN.0b013e31825018f7; citation_id=CR4

citation_journal_title=Alzheimers Dement; citation_title=Neuroinflammation in Alzheimer's disease: current evidence and future directions; citation_author=V Calsolaro, P Edison; citation_volume=12; citation_publication_date=2016; citation_pages=719-732; citation_doi=10.1016/j.jalz.2016.02.010; citation_id=CR5

citation_journal_title=Parkinsonism Relat Disord; citation_title=Parkinson's and Alzheimer's diseases: focus on mild cognitive impairment; citation_author=AD Korczyn; citation_volume=22; citation_issue=Suppl 1; citation_publication_date=2016; citation_pages=S159-S161; citation_doi=10.1016/j.parkreldis.2015.09.053; citation_id=CR6

citation_journal_title=J Cell Biol; citation_title=Microglia in Alzheimer's disease; citation_author=DV Hansen, JE Hanson, M Sheng; citation_volume=217; citation_publication_date=2018; citation_pages=459-472; citation_doi=10.1083/jcb.201709069; citation_id=CR7

citation_journal_title=Exp Ther Med; citation_title=PYNOD reduces microglial inflammation and consequent neurotoxicity upon lipopolysaccharides stimulation; citation_author=Q Zeng, C Hu, R Qi, D Lu; citation_volume=15; citation_publication_date=2018; citation_pages=5337-5343; citation_id=CR8

citation_journal_title=Dis Model Mech; citation_title=Molecular biomarkers of Alzheimer’s disease: progress and prospects; citation_author=T Lashley, JM Schott, P Weston, CE Murray; citation_volume=11; citation_publication_date=2018; citation_pages=dmm031781; citation_doi=10.1242/dmm.031781; citation_id=CR9

citation_journal_title=J Intern Med; citation_title=Biomarkers for Alzheimer's disease: current status and prospects for the future; citation_author=K Blennow, H Zetterberg; citation_volume=284; citation_publication_date=2018; citation_pages=643-663; citation_doi=10.1111/joim.12816; citation_id=CR10

citation_journal_title=Clin Nutr; citation_title=Hypohomocysteinemia may increases the risk of dementia and Alzheimer's disease; citation_author=L Zou, Y Zhu; citation_volume=40; citation_publication_date=2021; citation_pages=5630; citation_doi=10.1016/j.clnu.2021.09.005; citation_id=CR11

citation_journal_title=The Lancet Neurology; citation_title=CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis; citation_author=B Olsson, R Lautner, U Andreasson, A Öhrfelt; citation_volume=15; citation_publication_date=2016; citation_pages=673-684; citation_doi=10.1016/S1474-4422(16)00070-3; citation_id=CR12

citation_journal_title=Endocr Metab Immune Disord Drug Targets; citation_title=The role of chemokines in Alzheimer’s disease; citation_author=A Jorda, J Campos-Campos, A Iradi, M Aldasoro; citation_volume=20; citation_publication_date=2020; citation_pages=1383-1390; citation_doi=10.2174/1871530320666200131110744; citation_id=CR13

citation_journal_title=Immunity; citation_title=The chemokine superfamily revisited; citation_author=A Zlotnik, O Yoshie; citation_volume=36; citation_publication_date=2012; citation_pages=705-716; citation_doi=10.1016/j.immuni.2012.05.008; citation_id=CR14

citation_journal_title=Cell Biosci.; citation_title=Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation; citation_author=H Chidambaram, R Das, S Chinnathambi; citation_volume=10; citation_publication_date=2020; citation_pages=109; citation_doi=10.1186/s13578-020-00474-4; citation_id=CR15

citation_journal_title=Brain Pathol; citation_title=Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer’s disease; citation_author=A Sokolova, MD Hill, F Rahimi, LA Warden; citation_volume=19; citation_publication_date=2009; citation_pages=392-398; citation_doi=10.1111/j.1750-3639.2008.00188.x; citation_id=CR16

citation_journal_title=Front Neurol; citation_title=Roles of microglial and monocyte chemokines and their receptors in regulating Alzheimer's disease-associated amyloid-β and tau pathologies; citation_author=JR Guedes, T Lao, AL Cardoso, J Khoury; citation_volume=9; citation_publication_date=2018; citation_pages=549; citation_doi=10.3389/fneur.2018.00549; citation_id=CR17

citation_journal_title=Nature; citation_title=Structural basis of CXC chemokine receptor 2 activation and signalling; citation_author=K Liu, L Wu, S Yuan, M Wu; citation_volume=585; citation_publication_date=2020; citation_pages=135-140; citation_doi=10.1038/s41586-020-2492-5; citation_id=CR18

citation_journal_title=J Alzheimers Dis; citation_title=Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease; citation_author=M Reale, C Iarlori, C Feliciani, D Gambi; citation_volume=14; citation_publication_date=2008; citation_pages=147-159; citation_doi=10.3233/JAD-2008-14203; citation_id=CR19

citation_journal_title=Alzheimers Dement; citation_title=Inflammatory biomarkers in Alzheimer's disease plasma; citation_author=AR Morgan, S Touchard, C Leckey, C O'Hagan; citation_volume=15; citation_publication_date=2019; citation_pages=776-787; citation_doi=10.1016/j.jalz.2019.03.007; citation_id=CR20

citation_journal_title=Front Neurosci; citation_title=Decreased CX3CL1 levels in the cerebrospinal fluid of patients with Alzheimer’s disease; citation_author=JR Perea, A Lleó, D Alcolea, J Fortea; citation_volume=12; citation_publication_date=2018; citation_pages=609; citation_doi=10.3389/fnins.2018.00609; citation_id=CR21

citation_journal_title=Ann N Y Acad Sci; citation_title=The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects; citation_author=O Thuc, N Blondeau, J Nahon, C Rovère; citation_volume=1351; citation_publication_date=2015; citation_pages=127-140; citation_doi=10.1111/nyas.12855; citation_id=CR22

citation_journal_title=Sci Rep; citation_title=Plasma MCP-1 and cognitive decline in patients with Alzheimer's disease and mild cognitive impairment: a two-year follow-up study; citation_author=WJ Lee, YC Liao, YF Wang, IF Lin; citation_volume=8; citation_publication_date=2018; citation_pages=1280; citation_doi=10.1038/s41598-018-19807-y; citation_id=CR23

citation_journal_title=PLoS ONE; citation_title=CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease; citation_author=K Westin, P Buchhave, H Nielsen, L Minthon; citation_volume=7; citation_publication_date=2012; citation_pages=e30525; citation_doi=10.1371/journal.pone.0030525; citation_id=CR24

citation_journal_title=Neurosci Lett; citation_title=Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease; citation_author=TS Kim, HK Lim, JY Lee, DJ Kim; citation_volume=436; citation_publication_date=2008; citation_pages=196-200; citation_doi=10.1016/j.neulet.2008.03.019; citation_id=CR25

citation_journal_title=Alzheimers Dement; citation_title=Comparing biological markers of Alzheimer's disease across blood fraction and platforms: comparing apples to oranges; citation_author=SE O'Bryant, S Lista, RA Rissman, M Edwards; citation_volume=3; citation_publication_date=2016; citation_pages=27-34; citation_id=CR26

citation_journal_title=Neurodegener Dis Manag; citation_title=Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics; citation_author=AE Villarreal, SE O'Bryant, M Edwards, S Grajales; citation_volume=6; citation_publication_date=2016; citation_pages=203-213; citation_doi=10.2217/nmt-2015-0009; citation_id=CR27

citation_journal_title=Dement Geriatr Cogn Dis Extra; citation_title=Two blood monocytic biomarkers (CCL15 and p21) combined with the mini-mental state examination discriminate Alzheimer’s disease patients from healthy subjects; citation_author=T Hochstrasser, J Marksteiner, M Defrancesco, EA Deisenhammer; citation_volume=1; citation_publication_date=2011; citation_pages=297-309; citation_doi=10.1159/000330468; citation_id=CR28

citation_journal_title=Neurobiol Aging; citation_title=Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease; citation_author=J Marksteiner, G Kemmler, EM Weiss, G Knaus; citation_volume=32; citation_publication_date=2011; citation_pages=539-540; citation_doi=10.1016/j.neurobiolaging.2009.03.011; citation_id=CR29

citation_journal_title=Sci Rep; citation_title=A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort; citation_author=S Pedrini, VB Gupta, E Hone, J Doecke; citation_volume=7; citation_publication_date=2017; citation_pages=14057; citation_doi=10.1038/s41598-017-14020-9; citation_id=CR30

citation_journal_title=Front Aging Neurosci; citation_title=Better identification of cognitive decline with interleukin-2 than with amyloid and tau protein biomarkers in amnestic mild cognitive impairment; citation_author=CS Liang, CL Tsai, GY Lin, JT Lee; citation_volume=13; citation_publication_date=2021; citation_pages=670115; citation_doi=10.3389/fnagi.2021.670115; citation_id=CR31

citation_journal_title=J Clin Neurol; citation_title=Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology; citation_author=C Choi, JH Jeong, JS Jang, K Choi; citation_volume=4; citation_publication_date=2008; citation_pages=84-88; citation_doi=10.3988/jcn.2008.4.2.84; citation_id=CR32

citation_journal_title=Geriatr Gerontol Int; citation_title=Peripheral cytokines, C-X-C motif ligand10 and interleukin-13, are associated with Malaysian Alzheimer's disease; citation_author=DS MohdHasni, SM Lim, AV Chin, MP Tan; citation_volume=17; citation_publication_date=2017; citation_pages=839-846; citation_doi=10.1111/ggi.12783; citation_id=CR33

citation_journal_title=J Neurol Neurosurg Psychiatry; citation_title=Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies; citation_author=X Shen, L Niu, Y Wang, X Cao; citation_volume=90; citation_publication_date=2019; citation_pages=590-598; citation_doi=10.1136/jnnp-2018-319148; citation_id=CR34

citation_journal_title=Plos Med; citation_title=Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement; citation_author=D Moher, A Liberati, J Tetzlaff, DG Altman; citation_volume=6; citation_publication_date=2009; citation_pages=e1000097; citation_doi=10.1371/journal.pmed.1000097; citation_id=CR35

citation_journal_title=BMC Med Res Methodol; citation_title=Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range; citation_author=X Wan, W Wang, J Liu, T Tong; citation_volume=14; citation_publication_date=2014; citation_pages=135; citation_doi=10.1186/1471-2288-14-135; citation_id=CR36

citation_journal_title=Stat Methods Med Res; citation_title=Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range; citation_author=D Luo, X Wan, J Liu, T Tong; citation_volume=27; citation_publication_date=2018; citation_pages=1785-1805; citation_doi=10.1177/0962280216669183; citation_id=CR37

citation_journal_title=J Clin Epidemiol; citation_title=Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods; citation_author=JO Friedrich, NKJ Adhikari, J Beyene; citation_volume=64; citation_publication_date=2011; citation_pages=556-564; citation_doi=10.1016/j.jclinepi.2010.09.016; citation_id=CR38

citation_journal_title=Bmc Med Res Methodol; citation_title=The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study; citation_author=JO Friedrich, NK Adhikari, J Beyene; citation_volume=8; citation_publication_date=2008; citation_pages=32; citation_doi=10.1186/1471-2288-8-32; citation_id=CR39

citation_journal_title=PLoS ONE; citation_title=Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease; citation_author=M Björkqvist, M Ohlsson, L Minthon, O Hansson; citation_volume=7; citation_publication_date=2012; citation_pages=e29868; citation_doi=10.1371/journal.pone.0029868; citation_id=CR40

citation_journal_title=PLoS ONE; citation_title=Inflammatory proteins in plasma are associated with severity of Alzheimer's disease; citation_author=R Leung, P Proitsi, A Simmons, K Lunnon; citation_volume=8; citation_publication_date=2013; citation_pages=e64971; citation_doi=10.1371/journal.pone.0064971; citation_id=CR41

citation_journal_title=Ann N Y Acad Sci; citation_title=Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels; citation_author=HD Soares, Y Chen, M Sabbagh, A Roher; citation_volume=1180; citation_publication_date=2009; citation_pages=56-67; citation_doi=10.1111/j.1749-6632.2009.05066.x; citation_id=CR42

citation_journal_title=Immunol Lett; citation_title=Bioplex analysis of plasma cytokines in Alzheimer’s disease and mild cognitive impairment; citation_author=KS Lee, JH Chung, KH Lee, M Shin; citation_volume=121; citation_publication_date=2008; citation_pages=105-109; citation_doi=10.1016/j.imlet.2008.09.004; citation_id=CR43

citation_journal_title=Am J Alzheimers Dis Other Demen; citation_title=Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer's disease; citation_author=MA Alsadany, HH Shehata, MI Mohamad, RG Mahfouz; citation_volume=28; citation_publication_date=2013; citation_pages=54-61; citation_doi=10.1177/1533317512467680; citation_id=CR44

citation_journal_title=Int J Mol Sci; citation_title=Increased c-x-c motif chemokine ligand 12 levels in cerebrospinal fluid as a candidate biomarker in sporadic amyotrophic lateral sclerosis; citation_author=P Andrés-Benito, M Povedano, R Domínguez, C Marco; citation_volume=21; citation_publication_date=2020; citation_pages=1-21; citation_doi=10.3390/ijms21228680; citation_id=CR45

citation_journal_title=Dement Geriatr Cogn Disord; citation_title=Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias; citation_author=I Blasko, W Lederer, H Oberbauer, T Walch; citation_volume=21; citation_publication_date=2006; citation_pages=9-15; citation_doi=10.1159/000089137; citation_id=CR46

citation_journal_title=J Alzheimers Dis; citation_title=Cognitive decline and Alzheimer's disease in old age: a sex-specific cytokinome signature; citation_author=V Boccardi, L Paolacci, D Remondini, E Giampieri; citation_volume=72; citation_publication_date=2019; citation_pages=911-918; citation_doi=10.3233/JAD-190480; citation_id=CR47

citation_journal_title=Aging (Milano); citation_title=Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer's disease (DAT): lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT; citation_author=S Bonaccorso, A Lin, C Song, R Verkerk; citation_volume=10; citation_publication_date=1998; citation_pages=316-323; citation_id=CR48

citation_journal_title=J Neuroimmunol; citation_title=Systemic immune aberrations in Alzheimer's disease patients; citation_author=K Bonotis, E Krikki, V Holeva, C Aggouridaki; citation_volume=193; citation_publication_date=2008; citation_pages=183-187; citation_doi=10.1016/j.jneuroim.2007.10.020; citation_id=CR49

citation_journal_title=Arq Neuropsiquiatr; citation_title=Chemokines in CSF of Alzheimer's disease patients; citation_author=JD Corrêa, D Starling, AL Teixeira, P Caramelli; citation_volume=69; citation_publication_date=2011; citation_pages=455-459; citation_doi=10.1590/S0004-282X2011000400009; citation_id=CR50

citation_journal_title=Biogerontology; citation_title=Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration; citation_author=MM Corsi, F Licastro, E Porcellini, G Dogliotti; citation_volume=12; citation_publication_date=2011; citation_pages=451-454; citation_doi=10.1007/s10522-011-9335-6; citation_id=CR51

citation_journal_title=Front Neurol; citation_title=Central nervous system and peripheral inflammatory processes in Alzheimer's disease: biomarker profiling approach; citation_author=C Delaby, A Gabelle, D Blum, S Schraen-Maschke; citation_volume=6; citation_publication_date=2015; citation_pages=181; citation_doi=10.3389/fneur.2015.00181; citation_id=CR52

citation_journal_title=Ann Neurol; citation_title=Neutrophil hyperactivation correlates with Alzheimer's disease progression; citation_author=Y Dong, J Lagarde, L Xicota, H Corne; citation_volume=83; citation_publication_date=2018; citation_pages=387-405; citation_doi=10.1002/ana.25159; citation_id=CR53

citation_journal_title=J Alzheimers Dis; citation_title=CCL23: a chemokine associated with progression from mild cognitive impairment to Alzheimer’s disease; citation_author=J Faura, A Bustamante, A Penalba, D Giralt; citation_volume=73; citation_publication_date=2020; citation_pages=1585-1595; citation_doi=10.3233/JAD-190753; citation_id=CR54

citation_journal_title=Neurobiol Aging; citation_title=MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels; citation_author=C Fenoglio, D Galimberti, C Lovati, I Guidi; citation_volume=25; citation_publication_date=2004; citation_pages=1169-1173; citation_doi=10.1016/j.neurobiolaging.2003.11.008; citation_id=CR55

citation_journal_title=Neurobiol Aging; citation_title=Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease; citation_author=D Galimberti, C Fenoglio, C Lovati, E Venturelli; citation_volume=27; citation_publication_date=2006; citation_pages=1763-1768; citation_doi=10.1016/j.neurobiolaging.2005.10.007; citation_id=CR56

citation_journal_title=Arch Neurol; citation_title=Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease; citation_author=D Galimberti, N Schoonenboom, P Scheltens, C Fenoglio; citation_volume=63; citation_publication_date=2006; citation_pages=538-543; citation_doi=10.1001/archneur.63.4.538; citation_id=CR57

citation_journal_title=J Clin Neurosci; citation_title=Chemokine profile in Alzheimer's disease: Results from a Mexican population; citation_author=F Gongora-Rivera, A Gonzalez-Aquines, X Ortiz-Jimenez, CM Garza; citation_volume=73; citation_publication_date=2020; citation_pages=159-161; citation_doi=10.1016/j.jocn.2019.12.051; citation_id=CR58

citation_journal_title=Alzheimers Res Ther; citation_title=Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients; citation_author=R Grewal, M Haghighi, S Huang, AG Smith; citation_volume=8; citation_publication_date=2016; citation_pages=43; citation_doi=10.1186/s13195-016-0211-0; citation_id=CR59

citation_journal_title=Alzheimers Dement (Amst); citation_title=Altered levels of blood proteins in Alzheimer's disease longitudinal study: results from Australian imaging biomarkers lifestyle study of ageing cohort; citation_author=VB Gupta, E Hone, S Pedrini, J Doecke; citation_volume=8; citation_publication_date=2017; citation_pages=60-72; citation_doi=10.1016/j.dadm.2017.04.003; citation_id=CR60

citation_journal_title=Alzheimer Dis Assoc Disord; citation_title=The association between circulating inflammatory markers and the progression of Alzheimer disease in norwegian memory clinic patients with mild cognitive impairment or dementia; citation_author=J Hazen, M Vistnes, ML Barca, RS Eldholm; citation_volume=34; citation_publication_date=2020; citation_pages=47-53; citation_doi=10.1097/WAD.0000000000000342; citation_id=CR61

citation_journal_title=J Shanghai Jiaotong Univ (Med Sci); citation_title=Study on detection biomarkers of Alzheimer's disease based on plasma immune and inflammatory proteins; citation_author=HE Lu, W Ying, XU Wei, C Sheng-di; citation_volume=37; citation_publication_date=2017; citation_pages=950-954; citation_id=CR62

citation_journal_title=Bmc Neurol; citation_title=Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β; citation_author=R Hesse, A Wahler, P Gummert, S Kirschmer; citation_volume=16; citation_publication_date=2016; citation_pages=185; citation_doi=10.1186/s12883-016-0707-z; citation_id=CR63

citation_journal_title=Bmc Neurol; citation_title=Identification of peripheral inflammatory markers between normal control and Alzheimer's disease; citation_author=SM Kim, J Song, S Kim, C Han; citation_volume=11; citation_publication_date=2011; citation_pages=51; citation_doi=10.1186/1471-2377-11-51; citation_id=CR64

citation_journal_title=Int Psychogeriatr; citation_title=Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease; citation_author=E King, JT O'Brien, P Donaghy, C Morris; citation_volume=31; citation_publication_date=2019; citation_pages=551-560; citation_doi=10.1017/S1041610218001126; citation_id=CR65

citation_journal_title=Curr Alzheimer Res; citation_title=Cerebrospinal fluid and blood CX3CL1 as a potential biomarker in early diagnosis and prognosis of dementia; citation_author=A Kulczyńska-Przybik, A Słowik, P Mroczko, B Borawski; citation_volume=17; citation_publication_date=2020; citation_pages=709-721; citation_doi=10.2174/1567205017666201109095657; citation_id=CR66

citation_journal_title=J Alzheimers Dis; citation_title=Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support?; citation_author=C Laske, K Stellos, GW Eschweiler, T Leyhe; citation_volume=15; citation_publication_date=2008; citation_pages=83-95; citation_doi=10.3233/JAD-2008-15107; citation_id=CR67

citation_journal_title=Neurosci Lett; citation_title=Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population; citation_author=K Li, D Dai, L Yao, X Gu; citation_volume=433; citation_publication_date=2008; citation_pages=125-128; citation_doi=10.1016/j.neulet.2008.01.002; citation_id=CR68

citation_journal_title=Alzheimer Dis Assoc Disord; citation_title=Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls; citation_author=DA Llano, J Li, JF Waring, T Ellis; citation_volume=26; citation_publication_date=2012; citation_pages=322-328; citation_doi=10.1097/WAD.0b013e31823b2728; citation_id=CR69

citation_journal_title=J Alzheimers Dis; citation_title=Cerebrospinal fluid neurotransmitters, cytokines, and chemokines in Alzheimer's and Lewy body diseases; citation_author=MV Lourenco, FC Ribeiro, LE Santos, D Beckman; citation_volume=82; citation_publication_date=2021; citation_pages=1067-1074; citation_doi=10.3233/JAD-210147; citation_id=CR70

citation_journal_title=Exp Gerontol; citation_title=Increased production of inflammatory cytokines in mild cognitive impairment; citation_author=S Magaki, C Mueller, C Dickson, W Kirsch; citation_volume=42; citation_publication_date=2007; citation_pages=233-240; citation_doi=10.1016/j.exger.2006.09.015; citation_id=CR71

citation_journal_title=J Neurol Neurosurg Psychiatry; citation_title=A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes; citation_author=NK Magdalinou, RW Paterson, JM Schott, NC Fox; citation_volume=86; citation_publication_date=2015; citation_pages=1240-1247; citation_doi=10.1136/jnnp-2014-309562; citation_id=CR72

citation_journal_title=Neuromolecular Med; citation_title=Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility; citation_author=N Mattsson, S Tabatabaei, P Johansson, O Hansson; citation_volume=13; citation_publication_date=2011; citation_pages=151-159; citation_doi=10.1007/s12017-011-8147-9; citation_id=CR73

citation_journal_title=J Neuroinflammation; citation_title=Glial activation and inflammation along the Alzheimer’s disease continuum; citation_author=K Nordengen, B Kirsebom, K Henjum, P Selnes; citation_volume=16; citation_publication_date=2019; citation_pages=46; citation_doi=10.1186/s12974-019-1399-2; citation_id=CR74

citation_journal_title=Immun Ageing; citation_title=Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer's disease; citation_author=E Porcellini, M Ianni, I Carbone, M Franceschi; citation_volume=10; citation_publication_date=2013; citation_pages=6; citation_doi=10.1186/1742-4933-10-6; citation_id=CR75

citation_journal_title=J Alzheimers Dis; citation_title=Soluble TREM2 and inflammatory proteins in Alzheimer's disease cerebrospinal fluid; citation_author=BS Rauchmann, A Sadlon, R Perneczky; citation_volume=73; citation_publication_date=2020; citation_pages=1615-1626; citation_doi=10.3233/JAD-191120; citation_id=CR76

citation_journal_title=Curr Alzheimer Res; citation_title=Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease; citation_author=M Reale, MA Kamal, L Velluto, D Gambi; citation_volume=9; citation_publication_date=2012; citation_pages=447-457; citation_doi=10.2174/156720512800492549; citation_id=CR77

citation_journal_title=Dement Geriatr Cogn Dis Extra; citation_title=Increased levels of chitotriosidase and YKL-40 in cerebrospinal fluid from patients with Alzheimer’s disease; citation_author=C Rosén, CH Andersson, U Andreasson, JL Molinuevo; citation_volume=4; citation_publication_date=2014; citation_pages=297-304; citation_doi=10.1159/000362164; citation_id=CR78

citation_journal_title=Neurodegener Dis Manag; citation_title=Definition and quantification of six immune- and neuroregulatory serum proteins in healthy and demented elderly; citation_author=CG Schipke, O Günter, C Weinert, P Scotton; citation_volume=9; citation_publication_date=2019; citation_pages=193-203; citation_doi=10.2217/nmt-2019-0003; citation_id=CR79

citation_journal_title=Ann Neurol; citation_title=Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression; citation_author=M Shi, J Bradner, AM Hancock, KA Chung; citation_volume=69; citation_publication_date=2011; citation_pages=570-580; citation_doi=10.1002/ana.22311; citation_id=CR80

citation_journal_title=PLoS ONE; citation_title=The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer's but not Parkinson's disease or dementia with Lewy bodies; citation_author=M Wennström, Y Surova, S Hall, C Nilsson; citation_volume=10; citation_publication_date=2015; citation_pages=e135458; citation_doi=10.1371/journal.pone.0135458; citation_id=CR81

citation_journal_title=Dement Geriatr Cogn Dis Extra; citation_title=Alterations of the neuroinflammatory markers IL-6 and TRAIL in Alzheimer's disease; citation_author=YY Wu, JL Hsu, HC Wang, SJ Wu; citation_volume=5; citation_publication_date=2015; citation_pages=424-434; citation_doi=10.1159/000439214; citation_id=CR82

citation_journal_title=Neurosci Lett; citation_title=The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study; citation_author=L Xu, Q Dong, L Xu, W Zou; citation_volume=749; citation_publication_date=2021; citation_pages=135710; citation_doi=10.1016/j.neulet.2021.135710; citation_id=CR83

citation_journal_title=Chin J Clin Rehab; citation_title=Levels of tumor necrosis factor alpha and interleukin-8 in serum and cerebrospinal fluid of patients with Alzheimer disease; citation_author=K Yu, Q Zhang, J Han; citation_volume=9; citation_publication_date=2005; citation_pages=21-23; citation_id=CR84

citation_journal_title=Am J Clin Pathol; citation_title=CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases; citation_author=J Zhang, I Sokal, ER Peskind, JF Quinn; citation_volume=129; citation_publication_date=2008; citation_pages=526-529; citation_doi=10.1309/W01Y0B808EMEH12L; citation_id=CR85

citation_journal_title=J Neuroimmunol; citation_title=Systemic immune system alterations in early stages of Alzheimer's disease; citation_author=R Zhang, RG Miller, C Madison, X Jin; citation_volume=256; citation_publication_date=2013; citation_pages=38-42; citation_doi=10.1016/j.jneuroim.2013.01.002; citation_id=CR86

citation_journal_title=Alzheimers Dement (Amst); citation_title=Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease; citation_author=Y Zhu, YL Chai, S Hilal, MK Ikram; citation_volume=7; citation_publication_date=2017; citation_pages=41-47; citation_doi=10.1016/j.dadm.2017.01.001; citation_id=CR87

citation_journal_title=Nat Med; citation_title=Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease; citation_author=KJ El, M Toft, SE Hickman, TK Means; citation_volume=13; citation_publication_date=2007; citation_pages=432-438; citation_doi=10.1038/nm1555; citation_id=CR88

citation_journal_title=J Neuroinflammation; citation_title=Neuroinflammation and fractalkine signaling in Alzheimer’s disease; citation_author=DJ Finneran, KR Nash; citation_volume=16; citation_publication_date=2019; citation_pages=30; citation_doi=10.1186/s12974-019-1412-9; citation_id=CR89

citation_journal_title=Acta Neuropathol; citation_title=Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment; citation_author=WT Hu, A Chen-Plotkin, SE Arnold, M Grossman; citation_volume=119; citation_publication_date=2010; citation_pages=669-678; citation_doi=10.1007/s00401-010-0667-0; citation_id=CR90

citation_journal_title=J Immunol; citation_title=Proteolytic activation of alternative CCR1 ligands in inflammation; citation_author=RD Berahovich, Z Miao, Y Wang, B Premack; citation_volume=174; citation_publication_date=2005; citation_pages=7341-7351; citation_doi=10.4049/jimmunol.174.11.7341; citation_id=CR91

citation_journal_title=Nat Chem Biol; citation_title=Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1; citation_author=Z Shao, Q Shen, B Yao, C Mao; citation_volume=18; citation_publication_date=2022; citation_pages=264-271; citation_doi=10.1038/s41589-021-00918-z; citation_id=CR92

citation_journal_title=J Immunol; citation_title=Enhancement of CCL15 expression and monocyte adhesion to Endothelial Cells (ECs) after Hypoxia/Reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs; citation_author=KH Park, TH Lee, CW Kim, J Kim; citation_volume=190; citation_publication_date=2013; citation_pages=6550-6558; citation_doi=10.4049/jimmunol.1202284; citation_id=CR93

citation_journal_title=J Neuroimmunol; citation_title=Amyloid-β-induced chemokine production in primary human macrophages and astrocytes; citation_author=HA Smits, A Rijsmus, JH Loon, JWY Wat; citation_volume=127; citation_publication_date=2002; citation_pages=160-168; citation_doi=10.1016/S0165-5728(02)00112-1; citation_id=CR94

citation_journal_title=Neurobiol Aging; citation_title=CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease; citation_author=T Kiyota, HE Gendelman, RA Weir, EE Higgins; citation_volume=34; citation_publication_date=2013; citation_pages=1060-1068; citation_doi=10.1016/j.neurobiolaging.2012.08.009; citation_id=CR95

citation_journal_title=J Neurosci; citation_title=CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease; citation_author=G Naert, S Rivest; citation_volume=31; citation_publication_date=2011; citation_pages=6208-6220; citation_doi=10.1523/JNEUROSCI.0299-11.2011; citation_id=CR96

citation_journal_title=Mol Neurodegener; citation_title=Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy; citation_author=H Ben-Yehuda, M Arad, RJ Peralta, E Sharon; citation_volume=16; citation_publication_date=2021; citation_pages=39; citation_doi=10.1186/s13024-021-00458-z; citation_id=CR97

citation_journal_title=Faseb J; citation_title=Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage; citation_author=F Guo, D Xu, Y Lin, G Wang; citation_volume=34; citation_publication_date=2020; citation_pages=1872-1884; citation_doi=10.1096/fj.201902203RR; citation_id=CR98

citation_journal_title=J Alzheimers Dis; citation_title=Cerebrospinal fluid C-C motif chemokine ligand 2 correlates with brain atrophy and cognitive impairment in Alzheimer’s disease; citation_author=A Kimura, N Yoshikura, Y Hayashi, T Inuzuka; citation_volume=61; citation_publication_date=2017; citation_pages=581-588; citation_doi=10.3233/JAD-170519; citation_id=CR99

citation_journal_title=J Neuroimmunol; citation_title=Expression and regulation in the brain of the chemokine CCL27 gene locus; citation_author=C Gunsolly, JD Nicholson, SJ Listwak, D Ledee; citation_volume=225; citation_publication_date=2010; citation_pages=82-90; citation_doi=10.1016/j.jneuroim.2010.04.019; citation_id=CR100

citation_journal_title=J Immunol; citation_title=Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC); citation_author=B Homey, W Wang, H Soto, ME Buchanan; citation_volume=164; citation_publication_date=2000; citation_pages=3465-3470; citation_doi=10.4049/jimmunol.164.7.3465; citation_id=CR101

citation_journal_title=Exp Cell Res; citation_title=Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues; citation_author=AT Weeraratna, A Kalehua, I DeLeon, D Bertak; citation_volume=313; citation_publication_date=2007; citation_pages=450-461; citation_doi=10.1016/j.yexcr.2006.10.028; citation_id=CR102

citation_journal_title=J Clin Invest; citation_title=CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model; citation_author=M Krauthausen, MP Kummer, J Zimmermann, E Reyes-Irisarri; citation_volume=125; citation_publication_date=2015; citation_pages=365-378; citation_doi=10.1172/JCI66771; citation_id=CR103

citation_journal_title=Mol Neurobiol; citation_title=Targeting CCR3 to reduce amyloid-β production, tau hyperphosphorylation, and synaptic loss in a mouse model of Alzheimer’s disease; citation_author=C Zhu, B Xu, X Sun, Q Zhu; citation_volume=54; citation_publication_date=2017; citation_pages=7964-7978; citation_doi=10.1007/s12035-016-0269-5; citation_id=CR104

citation_journal_title=Curr Alzheimer Res; citation_title=IL-8 and MCP-1 impact on tau phosphorylation and phosphatase activity; citation_author=M Vaz, C Domingues, D Trindade, C Barra; citation_volume=17; citation_publication_date=2020; citation_pages=985-1000; citation_doi=10.2174/1567205017666201130091129; citation_id=CR105

citation_journal_title=Biochem Biophys Res Commun; citation_title=CXCL8 protects human neurons from amyloid-beta-induced neurotoxicity: relevance to Alzheimer's disease; citation_author=null Ashutosh, W Kou, R Cotter, K Borgmann; citation_volume=412; citation_publication_date=2011; citation_pages=565-571; citation_doi=10.1016/j.bbrc.2011.07.127; citation_id=CR106

citation_journal_title=PLoS ONE; citation_title=Neuronal Cx3cr1 deficiency protects against amyloid β-induced neurotoxicity; citation_author=J Dworzak, B Renvoisé, J Habchi, EV Yates; citation_volume=10; citation_publication_date=2015; citation_pages=e127730; citation_doi=10.1371/journal.pone.0127730; citation_id=CR107

citation_journal_title=J Biol Chem; citation_title=CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease; citation_author=S Cho, B Sun, Y Zhou, TM Kauppinen; citation_volume=286; citation_publication_date=2011; citation_pages=32713-32722; citation_doi=10.1074/jbc.M111.254268; citation_id=CR108

citation_journal_title=Curr Alzheimer Res; citation_title=Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-tau accumulation in Alzheimer's Disease (AD) rodent models: is fractalkine a systemic biomarker for AD?; citation_author=JJ Merino, V Muneton-Gomez, MI Alvarez, A Toledano-Diaz; citation_volume=13; citation_publication_date=2016; citation_pages=403-412; citation_doi=10.2174/1567205013666151116125714; citation_id=CR109

citation_journal_title=Neurobiol Aging; citation_title=Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy; citation_author=KR Nash, DC Lee, JB Hunt, JM Morganti; citation_volume=34; citation_publication_date=2013; citation_pages=1540-1548; citation_doi=10.1016/j.neurobiolaging.2012.12.011; citation_id=CR110

citation_journal_title=J Neurol Neurosurg Psychiatry; citation_title=Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies; citation_author=K Lai, CS Liu, A Rau, KL Lanctot; citation_volume=88; citation_publication_date=2017; citation_pages=876-882; citation_doi=10.1136/jnnp-2017-316201; citation_id=CR111

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 15 Số 1

1-19

Thông tin tác giả